Product
Uromune
2 clinical trials
4 indications
Indication
Urinary Tract InfectionsIndication
Chronic Urinary Tract InfectionIndication
Urinary Tract InfectionIndication
Recurrent Urinary Tract InfectionClinical trial
Expanded Access Program Using Uromune for Patients With Recurrent Urinary Tract Infections (rUTI)Status:
Clinical trial
Protocol 19-01: Canadian, Single Centre, Pilot, Open Label Study to Evaluate the Efficacy and Safety of the Bacterial Vaccine Uromune in Treating Recurrent Urinary Tract Infections in Women.Status: Terminated, Estimated PCD: 2022-10-31